What is a Meningioma?

A meningioma is a type of tumor that develops from the meninges, the membrane that surrounds the brain and spinal cord. Most meningiomas (90 percent) are categorized as benign tumors, with the remaining 10 percent being atypical or malignant. In many cases, benign meningiomas grow slowly. This means that depending upon where it is located, … Read more

At Dana-Farber, Every Beam Tells a Story of Growth — and Survival

When Dana-Farber Cancer Institute was founded as the Children’s Cancer Research Foundation in 1947, childhood cancer was almost universally fatal. In the years since, as Dana-Farber’s researchers and clinicians have helped dramatically raise survival rates for many pediatric and adult cancers, its campus in Boston’s Longwood Medical Area has grown as well. Patients are the … Read more

New Research Shows Promise for Pediatric Brain Tumor Treatment

Every year, about 4,700 children in the United States are diagnosed with brain cancer –­ making it the most common solid tumor in children. It is also one of the most difficult cancers to treat. Brain tumors are the leading cause of cancer-related deaths in children under age 10 and the second leading cause of … Read more

What Does No Hair Loss During Chemo Mean?

Medically reviewed by Clare Sullivan, BSN, MPH, CRRN It’s well known that many chemotherapy medications used to treat cancer can bring undesirable side effects, such as hair loss, lack of appetite, and fatigue. But experiencing such symptoms is not an indication of whether cancer treatment is working. How does chemotherapy affect cells? Chemotherapy interferes with … Read more

How Cancer Researchers Are Working to Help Fight MERS Virus

Middle East Respiratory Syndrome (MERS), a viral respiratory illness has been in the news a lot lately.  MERS, first detected in Saudia Arabia in 2012, is caused by a coronavirus called “Middle East Respiratory Syndrome Coronavirus” (MERS-CoV). It isn’t known exactly where the virus comes from though many infectious disease experts think it is likely … Read more

How to Cope with Side Effects of Aromatase Inhibitors

Aromatase inhibitors (AIs) are some of the most effective treatments for post-menopausal women with hormonally sensitive breast cancer, such as estrogen-positive breast cancer. Compared to tamoxifen, AIs like Arimidex, Aromasin, and Femara are less likely to cause blood clots or raise the risk of endometrial cancer. The drug also helps reduce the risk of recurrence. However, … Read more

‘Chemobrain’ Added to Cancer Survivorship Guidelines

Cognitive dysfunction is a common and frustrating side effect for many patients who undergo chemotherapy. The condition – also called “chemobrain” – can create problems with memory, attention and concentration, information processing, and mental skills used for organizing and scheduling. For many years, medical professionals were skeptical that these cognitive issues were a real side effect of … Read more

Precision Medicine for Lung Cancer Marks Tenth Anniversary

Ten years ago researchers at Dana-Farber and in Japan published a study showing that lung cancer patients whose tumors had a malfunctioning version of a protein called Epidermal Growth Factor Receptor (EGFR) responded dramatically to a drug that specifically targets the EGFR protein. The findings launched the era of precision medicine for lung cancer, transforming … Read more

Star-Studded Support for Dana-Farber

A group of influential theater owners known as the Variety Club of New England were touring Boston Children’s Hospital in 1947 when they happened upon a tiny basement laboratory. Here, Sidney Farber, MD, was conducting research that would lead to the first remissions in pediatric leukemia. The men were so impressed by Farber they decided to … Read more

CELLmates Take on Boston Marathon

By Tim O’Neill In 2006, my then 33-years-young wife, Kirsten, was diagnosed with Stage III rectal cancer. Her diagnosis was completely unexpected; she was young, a non-smoker and in overall good health. She had chemotherapy and multiple surgeries. Thankfully, we navigated the treatment with an excellent team of healthcare providers, loving family and caring friends. … Read more

New Experimental Breast Cancer Drug Shows Promise

Reports of an experimental drug that slowed advanced breast cancer in a clinical trial have stirred excitement at a national research meeting and breathed new life into a cancer-fighting strategy that had seemed to falter. In one study, the drug, palbociclib, doubled the length of time without disease progression in patients with metastatic estrogen receptor-positive breast … Read more

Young Patient Inspires with Fashion and Beauty Blog

When 15-year-old Karina Moreira sat down with Brazilian model Gisele Bundchen in December 2013, the two traded beauty tips, talked fashion, and took turns applying makeup. They spoke in their native Portuguese and laughed with family and friends. The experience, Moreira says, one that she will remember for the rest of her life. But the … Read more